Rosetta Genomics Ltd (ROSG) is traded on Nasdaq Capital Markets in USA. It is located in ISRAEL and employs 77 people. Rosetta Genomics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Nano-Cap' category with current market capitalization of 3.25 M. Rosetta Genomics Ltd has 3.09 M outstanding shares of which 437.29 K shares are at this time shorted by private and institutional investors with about 6.64 trading days to cover.
ROSETTA GENOMICS currently holds about 6.24 M in cash with (10.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.34 which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Rosetta Genomics Probability Of Bankruptcy